Audio

Thomas Edwards

Thomas Edwards discusses potential benefits of exercise in patients with MS with severe mobility disability.

Audio

Paulo Fontoura, MD, PhD

Dr. Fontoura examines the effect that ocrelizumab has on the composite end point of no evidence of disease progression in MS.

Video

Harold Moses Jr, MD

At the 39th Annual Contemporary Clinical Neurology Symposium, Dr. Moses discusses strategies for remyelination and neuropreservation in multiple...

Video

Peter Chin, MD

Dr. Chin discusses the results of several studies presented at the 2016 Annual Meeting of the CMSC that relate to ocrelizumab.

Video

Frederick Munschauer, MD

At the 2016 CMSC Annual Meeting, Dr. Munschauer discussed the results of three studies that used real-world data to look at relapse rates,...

Conference Coverage

VIDEO: Novel tools measure disease progression in MS

The visual system is relevant and accessible for the study of multiple sclerosis and can aid in the measurement of neuronal and axonal injury.

Video

Brian Sandroff, PhD

At the ACTRIMS 2016 Forum, Dr. Sandroff discusses whether exercise can improve inhibitory control in patients with MS.

Video

Peter Chin, MD

At the ACTRIMS 2016 Forum, Dr. Chin discussed top-line results from the ORATORIO trial of ocrelizumab in patients with primary progressive MS and...

Pages